| (DKK) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 34.00M | — |
| Operating expense | — | — |
| Net income | -394.00M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, ZEAL.CO returned -23.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -32.1% |
| 1 year | -23.9% |
| 5 years | +63.4% |
| 10 years | +182.9% |
| All-time high | kr 930.00 (Jul 2024) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what kr1,000 in ZEAL.CO would be worth today ›No. Zealand Pharma A/S has not paid a dividend in the past 12 months.
Zealand Pharma A/S is part of the Healthcare sector.
Zealand Pharma A/S has a market cap of 21.59B DKK, based on the latest quote.
Zealand Pharma A/S is scheduled to report earnings on Nov 12, 2026.
